Consolidated Statements of Operations - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Operating expenses:
Research and development	$ 5,568,777	$ 1,524,395	$ 15,393,089	$ 4,569,072
General and administrative	1,639,026	499,421	4,524,859	1,472,671
Total operating expenses	7,207,803	2,023,816	19,917,948	6,041,743
Loss from operations	(7,207,803)	(2,023,816)	(19,917,948)	(6,041,743)
Interest and other income (expense)	13,219	(279,802)	45,233	(619,645)
Change in fair value of warrant liability		(32,005)		(14,563)
Change in fair value of embedded derivative liabilities		204,000		274,800
Loss on extinguishment of debt		(2,444,516)		(2,444,516)
Net loss	$ (7,194,584)	$ (4,576,139)	$ (19,872,715)	$ (8,845,667)
Net loss per common share, basic and diluted	$ (0.38)	$ (0.41)	$ (1.04)	$ (0.80)
Weighted average common shares outstanding, basic and diluted	19,149,906	11,108,144	19,149,579	11,108,144